In a recent study twenty-nine SIRS patients with a serum C-reactive protein (CRP) level above 10 mg/dL, received a synbiotic composition consisting of Bifidobacterium breve and Lactobacillus casei, in combination with galactooligosaccharides. The gene discussed is CRP; the disease is systemic inflammatory response syndrome.